Bridgeway Capital Management, LLC Diagnostics & Research

Bridgeway Capital Management, LLC

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
NEOG Neogen Corp	$3.24B	$5.26 Million 0.12% of portfolio	313,100	Q3 2024 Reduced 8.74%
FLGT Fulgent Genetics, Inc.	$541M	$2.57 Million 0.06% of portfolio	118,110	Q3 2024 Reduced 4.41%
MEDP Medpace Holdings, Inc.	$10.5B	$1.49 Million 0.03% of portfolio	4,480	Q1 2024 New
IQV Iqvia Holdings Inc.	$37.5B	$710,000 0.02% of portfolio	3,000	Q2 2024 Reduced 74.58%
SERA Sera Prognostics, Inc.	$180M	$704,000 0.02% of portfolio	90,305	Q3 2024 Added 4.88%
A Agilent Technologies, Inc.	$39.6B	$534,000 0.01% of portfolio	3,600	Q2 2024 Reduced 74.65%
BDSX Biodesix Inc	$46.4M	$506,000 0.01% of portfolio	284,511	Q3 2024 Added 53.74%
PSNL Personalis, Inc.	$155M	$460,000 0.01% of portfolio	85,600	Q3 2024 Reduced 36.87%
ACRS Aclaris Therapeutics, Inc.	$253M	$225,000 0.01% of portfolio	199,119	Q3 2024 Added 32.13%
ENZ Enzo Biochem Inc	$47.7M	$202,000 0.0% of portfolio	180,800	Q3 2024 Added 36.87%
XGN Exagen Inc.	$63.6M	$67,000 0.0% of portfolio	21,800	Q2 2024 Reduced 46.57%
STIM Neuronetics, Inc.	$23.2M	$36,000 0.0% of portfolio	48,005	Q3 2024 Reduced 42.17%
VNRX Volitionrx LTD	$48.1M	$14,000 0.0% of portfolio	24,180	Q3 2024 Reduced 86.12%

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.